a43f31b272
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
4.0 KiB
4.0 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO PHARMACY BENEFITS MANAGERS. | Over 80% of pharmaceuticals in the United States are purchased through pharmacy benefits manager (“PBM”) networks. PBMs serve as intermediaries between health plans, pharmaceutical manufacturers and pharmacies, and PBMs establish networks for consumers to receive reimbursement for drugs. | us/states/de | Delaware General Assembly | 150 | HB 194 | Delaware HB 194 (150) |
|
enacted |
|
2 | 9 | 2 | 2019-06-10 | 2019-07-17 | openstates | ocd-bill/8a400807-a4be-4d19-9c3c-4e9c1edee85a | https://legis.delaware.gov/BillDetail?LegislationId=47636 | b1a51a30de59cc97f4cf8e43040112b670ec6977b05beed422a8c13869e65b6e | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware HB 194 (150) — AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO PHARMACY BENEFITS MANAGERS.
Over 80% of pharmaceuticals in the United States are purchased through pharmacy benefits manager (“PBM”) networks. PBMs serve as intermediaries between health plans, pharmaceutical manufacturers and pharmacies, and PBMs establish networks for consumers to receive reimbursement for drugs.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- 3/5 — 21–0 (pass) · upper
- 3/5 — 38–0 (pass) · lower
Sponsors
- Andria L. Bennett — primary (person)
- Trey Paradee — primary (person)
- Anthony Delcollo — cosponsor (person)
- Bryan Townsend — cosponsor (person)
- Daniel B. Short — cosponsor (person)
- David P. Sokola — cosponsor (person)
- Jeffrey N. Spiegelman — cosponsor (person)
- John J. Viola — cosponsor (person)
- Kimberly Williams — cosponsor (person)
- Krista Griffith — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Quinton Johnson — cosponsor (person)
- Raymond Seigfried — cosponsor (person)
- Sean Matthews — cosponsor (person)
- Sherry Dorsey Walker — cosponsor (person)
- Stephanie L. Hansen — cosponsor (person)
- William Bush — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2019-06-10 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
introduction, referral-committee - 2019-06-12 Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 10 On Its Merits
committee-passage - 2019-06-18 Amendment HA 1 to HB 194 - Introduced and Placed With Bill
amendment-introduction - 2019-06-18 Amendment HA 1 to HB 194 - Passed In House by Voice Vote
amendment-passage - 2019-06-18 Passed By House. Votes: 38 YES 3 ABSENT
passage - 2019-06-18 Assigned to Banking, Business & Insurance Committee in Senate
introduction, referral-committee - 2019-06-26 Reported Out of Committee (Banking, Business & Insurance) in Senate with 3 On Its Merits
committee-passage - 2019-06-27 Passed By Senate. Votes: 21 YES
passage - 2019-07-17 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/8a400807-a4be-4d19-9c3c-4e9c1edee85a. Confidence: reported (aggregated from official Delaware legislature records).